Gaba, FaizaAsh, KarenBlyuss, OlegBizzarri, NicoloKamfwa, PaulRamirez, Pedro T.Kotsopoulos, Ioannis C.Chandrasekaran, DhivyaGomes, NanaButler, JohnNobbenhuis, MarielleInd, ThomasHeath, OwenBarton, DesmondJeyarajah, ArjunBrockbank, EllyLawrence, AlexandraDilley, JamesManchanda, RanjitPhadnis, SaurabhGlobal Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR)2023-04-182023-04-182022-12-05Gaba, F, Ash, K, Blyuss, O, Bizzarri, N, Kamfwa, P, Ramirez, P T, Kotsopoulos, I C, Chandrasekaran, D, Gomes, N, Butler, J, Nobbenhuis, M, Ind, T, Heath, O, Barton, D, Jeyarajah, A, Brockbank, E, Lawrence, A, Dilley, J, Manchanda, R, Phadnis, S & Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR) 2022, 'Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer : protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative)', International Journal of Gynecological Cancer, vol. 32, no. 12, pp. 1606-1610. https://doi.org/10.1136/ijgc-2022-0041011048-891XORCID: /0000-0003-4081-6883/work/132961673https://hdl.handle.net/2164/20493Funding The study is supported by the Grampian Endowment Fund. Acknowledgements We are grateful to the members of the international steering committee. We acknowledge support provided by a number stakeholders including the University of Aberdeen, European Network of Young Gynae Oncologists (ENYGO) and Target Ovarian Cancer.5213450engSDG 3 - Good Health and Well-beingSurgeryOvarian CancerNEOADJUVANT CHEMOTHERAPY CYCLESDEBULKING SURGERYSURVIVALNUMBERIMPACTRC0254 Neoplasms. Tumors. Oncology (including Cancer)RD SurgeryOncologyRC0254RDJournal article10.1136/ijgc-2022-004101https://discovery.ucl.ac.uk/id/eprint/10160644/3212